Study to Compare Selective Internal Radiation Therapy (SIRT) Versus Sorafenib in Locally Advanced Hepatocellular Carcinoma (HCC)

NCT01135056 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

360

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma

Interventions

DEVICE: SIR-Spheres
DRUG: Sorafenib tosylate

Sponsor

Singapore General Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]